CCT measurements a must for all glaucoma patients

Article

Central corneal thickness (CCT) measurements should be carries out on all glaucoma patients in order to help set an accurate target intraocular pressure (IOP) range.

Central corneal thickness (CCT) measurements should be carries out on all glaucoma patients in order to help set an accurate target intraocular pressure (IOP) range, according to Madhu Nagar and colleagues from the Clayton Hospital, West Yorkshire, UK.

A team of researchers carried out a retrospective analysis of existing glaucoma patients at the Clayton and Dewsbury Hospitals, UK between April 2002 and September 2006. IOP was measured using Goldman Tonometry and CCT measured with a hand-held ultrasound pachymeter.

A total of 168 patients were identified for the study. The average CCT was 538.6 µm and corneas were thicker in ocular hypertension patients than in those with normal tension glaucoma. IOP measurements were also found to be higher in patients with thicker corneas. Forty-nine eyes of 35 patients had two CCT readings taken over a period of time but no clinically significant differences were found between the two measurements.

The team suggest that CCT measurements be carried out on all glaucoma patients since the results can help set accurate target IOP ranges, which can in turn help prevent over-treatment.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.